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Endocytosisrriers equipped with targeting and cellular uptake mediating peptides have
attracted attention for numerous applications. The optimization of the carrier requires an understanding of
how their properties inﬂuence target cell recognition and uptake. We developed a dipalmitoylated
apolipoprotein E-derived peptide, named P2A2 as promising vector to mediate cellular uptake of potential
micellar and liposomal carriers. Confocal laser scanning microscopy (CLSM) and ﬂuorescence-activated cell
sorting (FACS) were used to get insight into the internalization mediated by carboxyﬂuoresceine-labeled
P2fA2 and the all-D amino acid analogue P2fa2 into brain capillary endothelial cells. Both peptide micelles
and liposomes entered cells via endocytosis. Cell surface heparan sulfate proteoglycans (HSPGs) were
involved in the internalization process of peptide-bearing liposomes characterized by a diameter of
100 nm, a low surface density of 100 peptide molecules per vesicle and a helical conformation of the
vector. In contrast, peptide micelles characterized by a diameter of about 10 nm, a high peptide density
caused by 19 associated molecules and a high conformational ﬂexibility of the vector sequence did not
address HSPG. Unspeciﬁc interactions between the carriers and membrane constituents predominate the
two uptake processes but stereospeciﬁc components seem to be involved. Both routes differ with respect
to transport efﬁciency. The results provide a prospective basis to optimize liposomes and micelles as drug
delivery systems.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionIn the recent decade liposomes have become a leading pharma-
ceutical carrier for numerous applications [1,2] and numerous
attempts have been made to explore the potential of micellar drug
delivery systems [3]. However, often the lacking ability of carriers to
recognize the target cells and to cross cellular barriers limits their use.
For site speciﬁc drug application, they need to be functionalized with
target-recognizing ligands such as proteins or peptides. Ideally, such
modiﬁcations serve to both targeting the desired cells and facilitatingin barrier; bEnd3, mouse brain
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l rights reserved.cellular uptake [4,5]. Targeting and drug transport across the blood
brain barrier (BBB) is a particular challenge [6].
Successful BBB passage has been reported for immunoliposomes
addressing the transferrin receptor [7] and core/shell nanoparticles
(micelles) assembled from cholesterol-terminated peptide-bound
polyethylene glycol [8].
Our attempts to developdelivery systems to improve drug transport
to and across the tight endothelial cell layer of brain capillaries have
been focused on the low density lipoprotein receptor (LDLr) and one of
its ligands, apolipoprotein E (apoE). Both are involved in the cellular
uptake of cholesterol-rich lipoproteins from the circulation [9], and the
receptor is expressed on brain capillary endothelial cells at levels
higher than those of other vessels [10]. Complexes of apoE-fragments
and lipoproteins, liposome-incorporated apoE, and synthetic peptides
derived from the LDLr-binding region of apoE complexed with lipids
have been proven to mimic natural lipoproteins [11,12].
Our interest has been focused upon the tandem dimer of the
(141–150) sequence corresponding to (LRKLR KRLLR)2 (A2) which
appears to be the shortest receptor-binding apoE peptide [13]. Its
covalent coupling to liposomes initiated an efﬁcient uptake into brain
capillary endothelial cells of different species [14]. N-terminal dipalmi-
toylation conferred a two domain structure upon the highly cationic A2
sequence [15]. The resulting lipopeptide, named P2A2, proved to be a
highly promising candidate for the preparation of potential lipid-based
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bles into well-deﬁned pure micellar peptide aggregates which were
stable down to nanomolar concentration [16]. Both micelles and P2A2-
liposomes were efﬁciently internalized into brain capillary endothelial
cells by a temperature dependent, endocytotic mechanism [15–17].
Pronounced uptake of liposomes modiﬁed with covalently bound
A2 into cells led to the conclusion that the complexesmayenter cells by
an LDLr-independent route. In studieswith ﬁbroblasts, heparan sulfate
proteoglycans (HSPGs) were identiﬁed as major components involved
in cell recognition [14]. Consensus sequences for efﬁcient HS binding
have been proposed for proteins [18]. The basic sequence (142–147) of
apoE may serve as a ligand for HSPG as it bears a high-afﬁnity binding
region for heparin, a highly sulfated variant of HS [19]. ApoE-related
clearance of remnant lipoproteins [20] and enhanced internalization of
LDL tagged with a (141–150) apoE peptide [21] involve HSPG.
Due to its poly-anionic nature, HSPGs bind a wide variety of cationic
molecules [22,23]. Furthermore, the ubiquitously cell surface-distrib-
utedHSPGs are actively internalized intovesicles [24]. This process could
allow for the passive, non selective uptake of interacting molecules and
particles. Because of nonspeciﬁc electrostatic interactions, the surface
accumulation and transport efﬁciency of basic molecules can be very
high. Thus, the cellular uptake of highly cationic sequences classiﬁed as
cell penetrating peptides (CPPs) such as TAT [25,26] and TAT-protein
conjugates [27], Antennapedia (Antp) and TAT-modiﬁed liposomes
[28,29], penetratin–protein conjugates and poly-arginine peptides
[30,31] has been reported to involve HSPGs. Also CPP-drug chimera
[32] and liposomes covered with cationized albumin [33] enter brain
capillary endothelial cells via HSPG-supported adsorptive endocytosis.
The high content of arginine and lysine residues renders A2
comparable to CPPs which allow cellular delivery of attached cargos
[34,35]. Conﬂicting results have been reported for their transport
routes. There is consensus that endocytosis strongly contributes to the
cellular uptake [36] but new ﬁndings for endocytosis-independent
transport routes [37,38] conﬁrm early observations of energy
independent import [39,40]. Moreover, there is increasing evidence
that the uptake mechanisms dynamically compete for ligands and the
contribution of the individual mode depends upon the peptide
concentration and the cargo [37,41,42].
The design of BBB-targeting carriers requires both an under-
standing of the characteristics of vector and cargo as well as of the
mechanism bywhich they interact and translocate into the target cells.
The P2A2 micelles and liposomes differ with respect to their archi-
tecture. Micelles are characterized by a hydrophobic core and polar
shell whereas vesicles are formed by lipid bilayers surrounding an
aqueous compartment. Furthermore, the potential carriers differ with
respect to stability, particle size, and,more importantly, with respect to
surface density of the vector peptide, its conformation and the
cytotoxic activity [15,17]. As a consequence, peptide-liposome com-
plexes and micellar structures are expected to activate different
cellular transport routes. Here,we examine the uptake ofﬂuorescence-
labeled P2A2 micelles and liposomes into mouse brain capillary
endothelial cells (bEnd3) by CLSM and FACS. We compare their uptake
behavior with that of the free A2 peptides and extend the studies to
micellar and liposomal systems formedwith all-D amino acid peptides.
In order to get insight into the mechanism of uptake and the role of
HSPGs in this process, experiments at different temperatures, under
conditions of energy depletion, and in the presence of HSPG-digesting
heparinase I, poly-L-lysine and heparin were performed.
2. Materials and methods
2.1. Materials
Protected amino acids were purchased from Novabiochem (Schel-
bach/Ts, Germany). Palmitic acid and other chemicals and solvents
used in peptide synthesis and puriﬁcation were from Fluka (Seelze,Germany). The lipids 1-palmitoyl-2-sn-glycero-phosphocholine
(POPC), Lissamine™ rhodamine B 1,2-dipalmitoyl-sn-glycero-3-phos-
phoethanolamine (Rhod-PE) were purchased from Avanti Polar Lipids
Inc. (Alabaster, USA). Other chemicals used for biophysical experi-
ments were from Merck (Darmstadt, Germany).
Tissue culture media were from Gibco (Karlsruhe, Germany).
Poly-L-lysine (N300,000) used for coating of cover slips as well as
poly-L-lysine (15,000–30,000), heparin, heparinase I, Dulbecco's
phosphate buffered saline (DPBS) and pronase E were obtained
from Sigma (Taufkirchen, Germany). BSA was purchased from Roth
(Karlsruhe, Germany).
2.2. Peptide synthesis and characterization
The peptides were synthesized on solid phase (TentaGel-S-RAM;
Rapp Polymere, Tübingen, Germany) using an ABI 433A automatic pep-
tide synthesizer (Applied Biosystems, Foster City, USA) following the
standard Fmoc (9-ﬂuorenylmethoxycarbonyl) chemistry protocol [43].
A2 was N-terminally ﬂuorescence labeled with 5(6)-carboxy-
ﬂuoresceine succinimidyl ester. The dipalmitoylated peptide P2A2 was
synthesized using a Dde-protected Fmoc-lysine derivative (Nα-(9-
ﬂuorenylmethoxycarbonyl)-Nɛ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-
ylidene)ethyl-L-lysine) as described before [15]. After coupling of the
ﬁnal tryptophan, the Dde and theN-terminal Fmoc groupswere cleaved
off and the two amino groups of the resin-bound peptidewere acylated
with palmitic acid. In the case of the dipalmitoylated peptides P2fA2 [16]
and P2fa2, the N-terminal lysine was incorporated by using Fmoc-Lys
(Fmoc)-OH. After removal of the Fmoc-groups and palmitoylation, the
Dde group of lysine at position three was cleaved off followed by
acylation with 5(6)-carboxyﬂuoresceine succinimidyl ester. Cleavage
from the resin with 10% phenol in triﬂuoroacetic acid (TFA) yielded the
C-terminally amidated peptides. The crude peptide products were puri-
ﬁed by preparative reversed-phase high-performance liquid chromato-
graphy (RP-HPLC) on a Shimadzu LC-8A system (Kyoto, Japan) operating
at 220 nm. An A300 Polyencap column (250×20 mm; Bischoff Ana-
lysentechnik und geräte, Leonberg, Germany) and a ﬂow gradient of
10ml/minwith 40–95%B (80% acetonitrile, 20%H2O, 0.1% TFA) in A (0.1%
TFA in H2O) over 70minwere used. The peptide purities were better than
95% as determined by analytical reversed-phase HPLC on an LC-2010C
instrument (Shimadzu, Kyoto, Japan) using a Prontosil 300-5-C18 column
(250×4.6 mm, Bischoff Analysentechnik und geräte, Leonberg, Germany).
Matrix-assisted laser desorption ionization time-of-ﬂight mass spectro-
metry (MALDI-TOF) on a Voyager-DE STR (Applied Biosystems, Foster City,
USA) conﬁrmed the theoretical masses of the peptides. The peptide
concentrations of the used solutions were calculated on the weighted
masses.
2.3. Liposome preparation
Small and large unilamellar vesicles (SUVs for spectroscopic and
LUVs for uptake experiments, respectively) composed of POPC and
containing 0.05mol% Rhod-PEwere prepared as described before [15].
Brieﬂy, dry lipid ﬁlms were suspended in buffer. SUVs were made by
soniﬁcation and LUVs were prepared by 35 extrusion steps through
two stacked polycarbonate ﬁlters with 100 nm pores using a
MiniExtruder (Avestin, Ottawa, Canada). The vesicle size distribution
was checked by dynamic light scattering on a Coulter N4 Plus
(Beckman Coulter Corp., USA) and was found to be narrowly centered
around 35 nm for SUVs and 100 nm for LUVs. Peptide-liposome
complexes were prepared by mixing peptide solutions and liposome
suspensions at appropriate concentrations.
2.4. Spectroscopic studies
Fluorescence measurements of 1 or 0.5 μM peptide solutions and
peptide-POPC SUVs at a molar lipid-to-peptide ratio of 1,000 were
Table 1
List of peptides
Abbreviation Sequence
fA2 Fluo-LRKLR KRLLR LRKLR KRLLR-NH2
P2A2 Palmitoyl-WK(Palmitoyl)G LRKLR KRLLR LRKLR KRLLR-NH2
P2fA2 Palmitoyl-K(Palmitoyl)WK(Fluo)G LRKLR KRLLR LRKLR KRLLR-NH2
P2fa2 Palmitoyl-K(Palmitoyl)WK(Fluo)G lrklr krllr lrklr krllr-NH2
fA2 and P2fA2 are labelled with 5(6)-carboxyﬂuoresceine (Fluo) at the N-terminal α-
amino group or the ɛ-amino group of K at position 3. Small letters refer to D-amino acid
residues.
Fig.1. CD characteristics of apoE-derived peptides. CD spectra of 20 μMP2A2 (thick solid
line), P2fA2 (thin solid line), and P2fa2 (dotted line) in 10 mM phosphate buffer, pH 7.4
and P2A2 (thick dashed/dotted line), P2fA2 (thin dashed/dotted dotted line), and P2fa2
(dashed line) in the presence of 1 mM POPC SUVs. [Θ] is the mean residual ellipticity.
Table 2
Fluorescence properties of A2 peptides
Peptide/carrier I/au
pH 7.4 pH 5
fA2 2265±60 1625±50
P2fA2 micelles 65±10 51±10
P2fA2 SUVs 1277±250 222±30
P2fa2 micelles 35±10 18±4
P2fa2 SUVs 1222±70 214±8
Fluorescence, I of carboxyﬂuoresceine-labelled peptides in 10mM phosphate buffer, pH
7.4 and in the presence of POPC SUVs at the wavelength of the emission maximum,
λmax=520±2 nm. The excitation wavelength was 488 nm. The peptide concentration
was 1 μM. The molar lipid/peptide ratio in POPC SUVs was 500.
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described elsewhere [15]. The samples were prepared in phosphate
buffer (10 mM NaH2PO4/Na2HPO4) adjusted to pH 7.4 or 5. Circular
dichroism (CD) measurements of peptides dissolved at 20 μM in
phosphate buffer and in 1mMPOPC SUV suspensionswere carried out
on a J-720 CD spectrometer (Jasco, Tokyo, Japan) and the peptide
helicity, α (%) , was calculated from the mean residual ellipticity at
222 nm as described before [15].
2.5. Uptake experiments
Immortalized mouse brain capillary endothelial cells (bEnd3)
[44] were cultured in a humidiﬁed atmosphere (37 °C, 5% CO2) with
Earle's minimal essential medium (MEM) supplemented with 10%
fetal bovine serum, penicillin G (100 units/ml), streptomycin
(100 μg/ml), and 2 mM N-acetyl-L-glutamine.
CLSM studies were performed as described recently [14,17].
bEnd3 cells were plated on poly-L-lysine coated coverslips (diameter
30 mm) positioned in 35 mm plastic culture dishes and cultured in
MEM. After one day, the plates were washed twice with Dulbecco`s
phosphate buffered saline (DPBS) containing 1 mg/ml D-glucose
(DPBS-G), pH 7.4. To monitor cellular uptake, the cells were exposed
to 1 μM peptide, peptide-liposome complexes (1 μM peptide, 1 mM
lipid) or blank liposomes as control in DPBS-G for 30 min at 37 or
4 °C. To study the effect of energy depletion (ED), cells were prein-
cubated with 10 mM NaN3 and 25 mM 2-deoxyglucose in DPBS for
1 h and afterwards treated for 30 min at 37 °C with peptides or
liposomes dissolved in the energy depletion (ED) medium. The role
of cell-surface HSPG in peptide and liposome uptake was studied by
removal of HSPG with heparinase I as previously reported [12].
Before adding peptide or liposomal test solutions, the cells were
incubated for 2 h with DPBS-G containing 10 units/ml heparinase I
and afterwards washed with DPBS-G [14]. Experiments with blocked
HSPG-mediated uptake were performed in the presence of 20 μg/ml
heparin or 0.05 μM poly-L-lysine in the test samples. After washing
three times with ice cold DPBS, samples were stored on ice until
measurement.
CLSM-pictures were taken within one hour using an LSM 510
inverted confocal laser scanning microscope equipped with a Plan-
Neoﬂuar 100×/1.3 Oil objective (Carl Zeiss, Oberkochen, Germany).
Rhodamine ﬂuorescence was excited by a 15 mW HeNe laser at
543 nm and pictures were taken using an LP 560 cut-off ﬁlter in front
of the detector. The pinhole was 300 μm and the laser power was 10%.
Excitation of carboxyﬂuoresceine was performed at the 488 nm line of
the 200 mW argon laser and the emission was registered using a BP
505-530 band-pass ﬁlter. The pinhole was stet to 300 μm. The
intensity was set to 8% and 50% in the case of the less ﬂuorescent
P2fa2.
For uptake studies using FACS, exponentially growing adherent
bEnd3 cells in six-well microtiter plates were washed with DPBS-G at
37 °C and then incubated with peptide micelles or liposomes for
30 min at 37 or 4 °C. The cells were washed once with ice cold DPBS-G
and incubated for 5 min with 1 ml of 0.1% pronase E in DPBS with
0.5 mM EDTA at 4 °C in order to detach the cells and remove surfacebound peptide. The reactionwas stopped by adding 0.7ml of 1% BSA in
DPBS. The cell suspension was centrifuged for 4 min at 4500 × g and
4 °C and the cell pellet was kept on ice. Immediately before the
analysis, the cells were resuspended in ice cold 0.5–1.0 ml of 1% BSA in
DPBS (depending on the cell density). Eight μl 0.5% trypan blue per
0.5 ml were added to further reduce extracellular ﬂuorescence [45].
The analysis of the carboxyﬂuoresceine ﬂuorescence was performed
with a FACSCalibur ﬂuorescence-activated cell sorter (BD Biosciences,
Franklin Lakes, USA) using a 530/30 nm bandpass ﬁlter. Cells for
analysis were gated by scatter plots and a minimum of 10,000 events
per sample was analyzed.
3. Results
3.1. ApoE peptides and their characterization
The sequences of the apoE-derived peptides are shown in Table 1.
The A2 tandem repeat (141–150)2 was N-terminally modiﬁed with
carboxyﬂuoresceine, and for adsorptive binding to liposomes, A2 and
its all-D amino acid analogue a2 were provided with a spacer
sequence bearing two palmitoyl chains and the ﬂuorescent dye.
Analytical HPLC and mass spectrometric analysis conﬁrmed the
theoretical mass of all peptides. The biophysical properties of P2fA2
and P2fa2 liposomes and peptide-liposome complexes have been
described [15,17]. The lipidated P2A2 forms micelles in aqueous
solution consisting of 19 molecules with a Stokes radius of 5.3 nm
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about 20% has been calculated for P2A2 and P2fA2. With binding to
liposomes, the peptide helicity distinctly increased, as demonstrated
by doubling of the negative ellipticity values (Fig. 1). At a molar lipid-
to-peptide ratio of 1,000, about 90–100 P2fA2 molecules cover the
surface of a vesicle with a diameter of 100 nm [17]. Thus, bothmicelles
and liposomes fulﬁll the prerequisite for recognition of cell surface-
located membrane constituents.
The P2fa2 peptide was synthesized in order to check whether
stereospeciﬁc interactions between micelles or liposomes and
membrane components are involved in cellular uptake. The mirror
CD characteristics of micellar and liposome-bound P2fa2 peptidesFig. 2. CLSM images of bEnd3 cells incubated for 30 min at 37 °C with P2fA2 POPC LUVs co
labeled lipid, (B) the carboxyﬂuoresceine ﬂuorescence of the peptide, (C) overlay and trypan
after incubation with P2A2 POPC LUVs containing 0.05 mol% Rhod-PE (centre): (E) 37 °C, (
deoxyglucose), (H) preincubation with HSPG-digesting heparinase I (20 units/ml). Images of
and 25 mM 2-deoxyglucose, (L) preincubation with heparinase I (20 units/ml). The peptideaccounts for about 20 and 40% helicity, respectively, of sequences
turned oppositely to the all-L amino acid peptides (Fig. 1).
Since the environment-dependent ﬂuorescence of carboxyﬂuor-
esceine has to be considered in interpretation of CLSM and FACS data,
we determined the ﬂuorescence of the different particulate structures
in suspension at physiological pH as well as the acidic pH reported for
late endosomes and lysosomes [46] (Table 2). The monomeric fA2 at
1 μM concentration is characterized by an emission maximum, λmax at
520 nm and a high ﬂuorescence intensity. Also the ﬂuorescence of
liposome-bound peptides at pH 7.4was high (1200–1300 au), whereas
the intensity of P2fA2 and P2fa2 micelles was distinctly reduced.
Carboxyﬂuoresceine ﬂuorescence is quenched at high concentrations.ntaining 0.05 mol% Rhod-PE (left): (A) monitoring the rhodamine ﬂuorescence of the
blue exclusion. (D) Image of cells incubated with peptide-free liposomes. Images of cells
F) 4 °C, (G) preincubated with energy-depleting medium (10 mM NaN3 and 25 mM 2-
P2fA2 micelle-treated cells (right): (I) 37 °C, (J) 4 °C, (K) preincubated with 10 mM NaN3
concentration was 1 μM, the lipid concentration 1 mM.
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account for the intensity decrease of micelles. As expected, with the
drop of the pH to 5, the ﬂuorescence intensity of both micellar and
liposome-bound peptide decreased.
3.2. Uptake studies
Cells incubated at 37 °C with P2fA2 and P2A2 liposomes showed a
strong vesicular intracellular ﬂuorescence (Fig. 2A,E). The ﬂuorescence
of both the rhodamine-labeled lipid (A) and P2fA2 (B) in liposomes are
co-localized (C) suggesting that the intact vesicles were internalized.
The intensive red ﬂuorescence of trypan blue at the cell membrane
conﬁrmed the integrity of the cell (C). No uptake was detected for
peptide-free liposomes (D). At 4 °C (F) and under condition of energy
depletion (G), liposome uptake was inhibited but the vesicles
accumulated at the cell surface as shown by themembrane-associated
rhodamine ﬂuorescence of P2A2 LUVs. P2fa2 liposomes showed a
similar uptake behavior: Efﬁcient internalization at 37 °C visualized by
the superimposing rhodamine and carboxyﬂuoresceine ﬂuorescence
resided in the cytoplasmic vesicles (Fig. 4Ba), and low uptake at 4 °C
and under energy depletion conditions (pictures not shown).
Also P2fA2 and P2fa2 micelles efﬁciently translocated the mem-
brane of brain capillary endothelial cells at 37 °C (Fig. 2I, Fig. 4Ca, Da)
whereas no uptake was detected at 4 °C (Fig. 2J) and under energy
depletion (Fig. 2K). The observations suggest that both peptide
micelles and liposomes activate temperature and energy dependent
endocytotic transport routes.
FACS was performed to analyse the carrier interaction with cells
more quantitatively (Fig. 3). Cell-associated carboxyﬂuoresceine
ﬂuorescence of P2fA2 micelles and liposomes at 37 °C incubation
was about 850 and 750 au/cell, respectively compared to about
250 au/cell at 4 °C suggesting that the major contribution to the
ﬂuorescence at 37 °C stems from particles located within the cells. For
P2fa2 micelles and liposomes, the difference between the ﬂuores-
cence intensity associated with internalized (37 °C) and rather cell
surface-bound (4 °C) peptide particles was even more pronounced.
Furthermore, the FACS signal intensities of P2fA2 micelles and
liposomes after 37 °C or 4 °C incubation were almost identical. Since
the ﬂuorescence of peptide micelles was low compared to liposomes
(Table 2), these observations lead to the suggestion that micelles were
actually much better internalized than liposomes. The same relationFig. 3. FACS analysis of bEnd3 cells incubated for 30 min with P2fA2 and P2fa2 micelles
and P2fA2 and P2fa2 POPC LUVs at 37 °C (black bars) and 4 °C (white bars). The peptide
concentration was 1 μM. The molar lipid/peptide ratio was 1000.was seen with P2fa2 micelles and liposomes (Fig. 3). The FACS signal
intensities of P2fA2 micelles was high compared to P2fa2 micelles.
Because of their correlation with intensity differences measured in
aqueous solution (Table 2), conclusions with respect to stereospeciﬁc
interactions could not be drawn. However, the different FACS signal
intensities (Fig. 3) but identical ﬂuorescence properties of P2fA2 and
P2fa2 liposomes (Table 2) clearly point to stereospeciﬁc components
in the interaction of the two peptide-liposome complexes with bEnd3
cells.
The treatment with HSPG-digesting heparinase I led to distinctly
reduced internalization of P2A2 LUVs into bEnd3 cells (compare
Fig. 2H with 2E) whereas the uptake of P2fA2 micelles was little
inﬂuenced (compare Fig. 2L with 2I). To gain further insight into
the role of HSPG into the uptake of liposomes, micelles as well as the
monomeric fA2 sequence into brain capillary endothelial cells, the
effect poly-L-lysine and heparin, two competitors of HSPG interac-
tions with cationic molecules, was investigated. Both, poly-L-lysine
(Fig. 4Ab, Bb) and heparin (Fig. 4Ac, Bc) drastically reduced the
uptake of P2A2 and P2fa2 liposomes. These results support the
suggestion that liposomes functionalized by adsorptive binding of
both the tandem dimer (141–150)2 of apoE and its enantiomer enter
cells via an HSPG-dependent mechanism. In contrast, the uptake of
peptide micelles was only little inhibited by poly-L-lysine (Fig. 4Cb,
Db) and heparin (Fig. 4Cc, Dc). Similar uptake patterns were observed
for the monomeric fA2 peptide (Fig. 4Ea–d). The peptide micelles and
the monomeric A2 sequence obviously do not address HSPG.
4. Discussion
Since trafﬁcking and bioavailability determine the efﬁciency of
targeted drug delivery systems, their design requires an under-
standing of the mechanism by which they interact with and trans-
locate into the target cells. Several factors affecting the entry and
intracellular fate of peptides and peptide-modiﬁed cargos and carriers
have been identiﬁed. Such factors are the type of peptide and its
structure, the kind of linkage between the vector and the cargo, the
nature of cargo, the size of carriers and the peptide density on their
surface [28,37,38,41,47–49].
Our studies, summarized in Table 3, suggest that P2A2- and P2a2-
modiﬁed liposomes andmicelles enter brain capillary endothelial cells
via different endocytotic routes. Cell treatment with heparinase or co-
incubation with heparin and poly-L-lysine inhibited the uptake of
liposomes suggesting that HSPGs are involved in the transport. In
contrast, the internalization of small peptide micelles was HSPG-
independent. Unspeciﬁc interactions between carriers and cells
predominate the uptake process but the differences in the uptake
mediated by the all-L and all-D peptides suggests that chirally speciﬁc
components might play a role at least in liposome interactionwith the
cells.
HSPGs on the cell surface are involved in a diversity of membrane
transport processes. They bind a large number of cationic molecules,
catalyze encounters between ligands and receptors and can be rapidly
internalized [22]. Lipid-associated apolipoprotein E [20] and apoE
peptide-bearing liposomes [21] have been described to adhere to and
enter cells in a HSPG-dependentmanner. As shown in this study, HSPG
is also actively involved in the uptake process of P2A2-bearing lipo-
somes into capillary endothelial cells. It may act as a nonspeciﬁc
receptor. Binding of apoE to heparin has been reported to be a two step
process with electrostatic interactions dominating the ﬁrst and
hydrophobic interactions contributing to the second step [50]. Binding
constants for P2A2 LUVs and heparansulfate have been determined to
be about 106 M−1, and 107 M−1 for heparin (Keller, personal commu-
nication). The noticeable internalization of liposomes bearing the
enantiomeric P2fa2 conﬁrms an unspeciﬁc component in interaction
between HSPG and the liposome-bound vector peptides. The uptake-
inhibiting effect of poly-L-lysine acting as competitor in nonspeciﬁc
Fig. 4. CLSM pictures of bEnd3 cells incubated for 30 min with (A) P2A2 LUVs containing 0.05 mol% Rhod-PE, (B) P2fa2 LUVs containing 0.05 mol% Rhod-PE, (C) P2fA2 micelles, (D)
P2fa2 micelles and (E) monomeric fA2: (a) 37 °C, (b) in the presence of 0.2 μM poly-L lysine and (c) 20 μg/ml heparin. The peptide concentration was 1 μM and molar lipid/peptide
ratio was 1000. The pictures were taken after addition of trypan blue to monitor the viability of the cells. In (A), the rhodamine ﬂuorescence was registered, (B) shows the overlay of
rhodamine and carboxyﬂuoresceine ﬂuorescence. In (C)–(E), the carboxyﬂuoresceine ﬂuorescence of the peptides is seen.
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Table 3
Summary of the uptake experiments with A2 peptides and A2 peptide-modiﬁed
liposomes and bEnd3 cells under different incubation conditions
Peptide/carrier 37 °C 4 °C ED HD H P-LL
P2A2/P2fA2 LUVs + ↓ ↓ − − −
P2fa2 LUVs + ↓ ↓ nd − −
P2fA2 micelles + ↓ ↓ + + +
P2fa2 micelles + ↓ ↓ + + +
fA2 + ↓ ↓ nd + +
Uptake was monitored using CLSM after 30 min of incubation at 37 °C, 4 °C, under
conditions of energy depletion (ED), after HSPG digestionwith heparinase I (HD), in the
presence of heparin (H) and in the presence of poly-L-Lysine (P-LL): + efﬁcient uptake, ↓
pronouncedly reduced uptake, − no detection of uptake, nd not determined. The
experimental details are described in the Materials and methods section and Fig. 4.
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groups of HSPG upon the lipopeptide-modiﬁed liposomes supports
the suggestion. Recently, we reported that the cellular uptake of
liposomes with A2 covalently linked to the distal end of PEG moieties
involves HSPG [14]. Thus, HSPG-mediated uptake seems to be
independent upon the kind of N-terminal peptide modiﬁcation,
liposome coupling and the mode of exposure on the liposome surface.
This suggestion is supported by the fact that both conventional and
PEG-modiﬁed liposomes tagged with 100 and 500 cell penetrating
TAT molecules are internalized into different cell lines via HSPG-
supported adsorptive endocytosis [51]. Also the conformation of our
surface-located apoE peptides, being unordered in the polar PEG shell
of liposomes [14] and largely helical in the lipid-bound state not does
not seem to inﬂuence the uptake mode.
Likely, properties such as the surface density of peptides and the
size of carriers determine the internalization process. We used in our
uptake experiments LUVs at a molar lipid/peptide ratio (l/p) of 1000
which corresponds to about 0.1 mol% peptide or 100 molecules on the
vesicle surface. Cell surface binding and internalization of Anten-
napedia- and TAT-modiﬁed small unilamellar vesicles have been
reported to require also about 100 covalently bound vector molecules
[28] and depends on HSPG expression on the target cells. More
detailed studies of the role of peptide density in the mode of uptake
showed that lipid vesicles with less than one mol% octa-arginine (R8)
of the total lipid are mainly taken up through clathrin-mediated
encocytosis, whereas liposomes with a high surface density of the
peptide (5 mol%) initiate macropinocytosis [41].
Also the small P2fA2 micelles entered cells via endocytosis but,
HSPGs did not seem to play a role. This is the more surprising as our
binding studies revealed high heparansulfate and heparin afﬁnity.
Interestingly, the uptake patterns of P2fA2 and P2fa2 micelles were
comparable to the behavior observed for the monomeric fA2
sequence. We suggest that interactions relevant for CPP uptake
determine the process. The low helicity of the peptides may be one
reason for the efﬁcient uptake. High conformational ﬂexibility has
been suggested to favor CPP-related transmembrane transport [52]
and more recent studies showed that structural polymorphism is
highly advantageous for transmembrane transport [53]. CPPs and
CPP-modiﬁed cargos with low molecular weight and thus being of
low size have different options to enter cells. They may be engulfed
in different cytoplasmic compartments or uniformly distributed
within the cell [37,38]. Thus, whereas R8 enters cells in an pathway
different form classical endocytosis, R8 modiﬁed N-terminally with
lipid-binding stearyl induces endocytosis [54]. Peptide concentration
and charge density of the sequences seem to modulate HSPG
recognition. Thus, the contribution of heparan sulfate to the uptake
of nona-arginine (R9) was found to be restricted to high peptide
concentrations [37]. Consistent with these results, HSPG was
involved in the uptake of the TAT peptide at 100 μM concentration
[26] but not required at low concentration (1 μM) [55]. Cross-linking
of HSPGs by polyvalent binding might provide a possible explanationfor the functionalization of HSPG at only high peptide concentration
[37]. Furthermore, the uptake of R8 and other model peptides with
high charge density appears to be less dependent on HSPG whereas
the TAT peptide can interact with cell surface HSPG at 10 μM
concentration [48]. The authors suggest that peptides with various
charge density address different cell surface proteoglycanes. Whether
peptide concentration-dependent HSPG clustering and charge den-
sity-dependent HSPG binding provide a basis for the different uptake
modes of P2A2-tagged liposomes and micelles remains speculative
so far.
Using carboxyﬂuoresceine to monitor peptide and cargo interac-
tions with cells, the environment-dependent ﬂuorescence properties
of the chromophore have to be considered. The ﬂuorescence of
micellar P2fA2 and P2fa2 is low and distinctly increases with peptide
binding to liposomes (Table 2). As a consequence, evaluating quan-
titative uptake data as provided by FACS analysis (Fig. 3), LUVs will
provide higher ﬂuorescence values than micelles at identical amounts
of internalized peptide even if incorporated into acidic compartments.
Based on the ratios of the ﬂuorescence intensities of micellar and
liposome-bound peptides, we suggest that the micelle internalization
might be much more efﬁcient than the HSPG-dependent liposome
uptake.
Furthermore, the ﬂuorescence of liposome-bound P2fA2 and P2fa2
is identical. Thus, the lower FACS intensities of the all-D peptide-
modiﬁed vesicles point to a reduced uptake compared to all-L peptide
liposomes and suggest the involvement of stereospeciﬁc components
in the HSPG-dependent uptake mode of liposomes. Previous studies
have shown that apoE dimer peptides bind to the LDL receptor with
reduced afﬁnity compared to the natural ligand LDL [13,14] as well as
to the class of lipoprotein receptors known as LDL receptor-related
protein (LRP) [56]. It has been suggested, that apoE peptide-bearing
LDLmight enter ﬁbroblasts in an HSPG-mediated, receptor-dependent
pathway [21] and both HSPG and LRP have been reported to be
involved in the neurotoxic effect and neuronal endocytosis of apoE
peptides [57,58]. Whether P2fA2 liposomes address a pathway in-
volving non-speciﬁcally binding HSPGs and the speciﬁc receptors
remains to be elucidated.
The FACS signal intensity of P2fa2 micelles was reduced compared
to all-L peptide micelles (Fig. 3) and correlated with the ﬂuorescence
in solution (Table 2). As a consequence, conclusions concerning
stereospeciﬁc components in the HSPG-independent pathway of
micelle uptake could not be drawn. For highly cationic CPPs conﬂicting
results have been obtained. Identical translocation has been reported
for L-and D-octa-arginine (R8) across the membrane of leukemia cells
[59] whereas the D-isoform of nona-arginine (R9) showed higher and
faster transduction compared to the all-L peptide into various cell
types which was associated with a different stability [38].
In conclusion, the efﬁcient endocytotic uptake of the different
colloidal systems into brain capillary endothelial cells emphasizes the
potential of the cationic apoE peptides as ligands for improved drug
delivery. The uptake of peptide-modiﬁed liposomes involves HSPGs,
which are expressed on endothelial cells of all blood vessels. In
contrast, peptide micelles follow an HSPG-independent endocytotic
pathway. Both uptake routes seem to be differently efﬁcient. The fact
that different uptake routes, such as clathrin-and caveolin-mediated
endocytosis and macropinocytosis lead to carrier localization in
different compartments with consequences for their intracellular
fate stresses the importance of understanding in detail the mode of
micelle and liposome internalization.
The reason for the differences in HSPG speciﬁcity is not clear yet.
The fact that liposomes enter cells via HSPG, which are expressed on
endothelial cells of all blood vessels and other cell surfaces will have
implications when it comes to target speciﬁcity. Generally, the
composition and structures of HSPGs of different cell types differ. The
question needed to address is to what extent cell speciﬁc targeting
via HSPG-dependent entry pathways can be achieved. Thus, it
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cationic residues in the (141–150) apoE peptide to distinct glycosea-
minglycan species such as found in brain [60] can provide a basis for
selective liposome delivery. Furthermore, the activation of an HSPG-
independent internalization route involving stereospeciﬁc compo-
nents by P2A2 micelles may provide a basis for the generation of cell-
selective carriers. The identiﬁcation of membrane constituents
contributing to the uptake of apoE peptide micelles and liposomes
into brain capillary endothelial cells remains an exiting task for
further studies.
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